论文部分内容阅读
目的探讨支气管动脉化疗和栓塞治疗耐药肺结核的临床价值。方法对156例经结核菌培养和药敏实验确诊为耐药肺结核的患者,采用经支气管动脉向病灶注入化疗药和阻断病灶区供血后再内科治疗,观察临床症状改善,病灶吸收、钙化,空洞缩小、闭合。结果通过与同期152例内科治疗疗效的对比,观察疗效的差异,说明哪一种治疗方法效果更好。结论治疗耐药肺结核介入治疗优于内科治疗。
Objective To investigate the clinical value of bronchial artery chemotherapy and embolization in the treatment of drug-resistant pulmonary tuberculosis. Methods One hundred and fifty-six patients with tuberculosis-resistant pulmonary tuberculosis were diagnosed as TB-resistant and susceptible to tuberculosis by bronchial artery injection of chemotherapeutic drugs and blocking the blood supply to the lesion area and then medical treatment. The improvement of clinical symptoms, lesion absorption, calcification, Empty narrow, closed. Results By comparing with the curative effect of 152 cases of medical treatment in the same period, we can observe the difference of curative effect and show which curative effect is better. Conclusion The treatment of drug-resistant pulmonary tuberculosis intervention is better than medical treatment.